Dell Reports Record Results: AI Momentum Remains Robust
Dell Technologies DELL delivered a strong report, with AI infrastructure once again reflecting the biggest highlight. Revenue climbed…
What’s Driving Quantum Computing’s Long-Term Growth Potential?
Quantum Computing Inc. QUBT or QCi completed the acquisition of NHanced Semiconductors, Inc., a U.S.-based advanced packaging foundry,…
AAOI Benefits From Strong 800G Demand: Can It Beat LITE & COHR?
Applied Optoelectronics AAOI is benefiting from accelerating demand for 800G optical transceivers, strengthening its position against Lumentum LITE…
Oracle’s Credit Risk Nears an 18-Year High: Can AI Backlog Save Stock?
Credit rating agencies have grown increasingly cautious on Oracle ORCL as the company’s aggressive artificial intelligence buildout strains…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…
Will Serve Robotics’ Healthcare Push Unlock a Bigger AI Opportunity?
Serve Robotics Inc. SERV is broadening its ambitions beyond autonomous sidewalk delivery, positioning itself as a multi-domain Physical…
Can Wegovy Pill’s Europe Push Help NVO Offset Mounting Pressures?
Last week, Novo Nordisk NVO secured a key regulatory win with the U.K. approval of the Wegovy pill…
Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?
Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
Intuitive Surgical Trades Near 2-Year Low: Is $600 Within Reach?
Intuitive Surgical ISRG is currently trading at a technically important juncture. After reaching an all-time high of $616 in…
Hims & Hers Expands Digital Healthcare Platform via New Care Offerings
Hims & Hers Health, Inc. HIMS has evolved into one of the leading consumer-focused digital healthcare platforms, using…
Can Oral Ozempic and Label Expansions Revive NVO’s Near-Term Growth?
Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…
Which Healthcare Giant Is the Better Bet?
Novo Nordisk NVO and Pfizer PFE are both pharmaceutical giants based in Denmark and the United States, respectively, with…